Current status of radical resection of lung cancer combined with coronary artery bypass grafting

Abstract

With the aging of the population, the incidence of lung cancer combined with coronary heart disease has been increasing yearly, which seriously threatens the life and health of patients. The treatment of lung cancer combined with coronary heart disease is rather difficult. Radical resection of lung cancer (RRLC) combined with coronary artery bypass grafting (CABG) is an effective treatment method. Compared with staged surgery, simultaneous surgery can avoid the delay of lung cancer treatment, the need for a second anesthesia, and patients' fear of reoperation, but it may increase surgical risks and postoperative complications. By examining updated literatures, this review summarizes current status of the application of RRLC combined with CABG for the treatment of lung cancer patients combined with coronary heart disease, so as to provide medical evidence for clinical application of this surgical procedure.